These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23313929)

  • 1. DemTect, PANDA, EASY, and MUSIC: cognitive screening tools with age correction and weighting of subtests according to their sensitivity and specificity.
    Kalbe E; Calabrese P; Fengler S; Kessler J
    J Alzheimers Dis; 2013; 34(4):813-34. PubMed ID: 23313929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. French translation and normation of the Parkinson Neuropsychometric Dementia Assessment (PANDA).
    Gasser AI; Kalbe E; Calabrese P; Kessler J; Von Allmen G; Rossier P
    J Neurol Sci; 2011 Nov; 310(1-2):189-93. PubMed ID: 21764080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia.
    Kalbe E; Kessler J; Calabrese P; Smith R; Passmore AP; Brand M; Bullock R
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):136-43. PubMed ID: 14758579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease.
    Kaszás B; Kovács N; Balás I; Kállai J; Aschermann Z; Kerekes Z; Komoly S; Nagy F; Janszky J; Lucza T; Karádi K
    Parkinsonism Relat Disord; 2012 Jun; 18(5):553-6. PubMed ID: 22405839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INECO Frontal Screening (IFS): a brief, sensitive, and specific tool to assess executive functions in dementia.
    Torralva T; Roca M; Gleichgerrcht E; López P; Manes F
    J Int Neuropsychol Soc; 2009 Sep; 15(5):777-86. PubMed ID: 19635178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for dementia syndromes: the Hungarian experience with the 7-Minute-Test].
    Kálmán J; Boda K; Bende Z; Janka Z
    Orv Hetil; 2003 Sep; 144(39):1929-38. PubMed ID: 14598572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
    Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
    Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
    Cahn-Weiner DA; Grace J; Ott BR; Fernandez HH; Friedman JH
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Barton B; Grabli D; Bernard B; Czernecki V; Goldman JG; Stebbins G; Dubois B; Goetz CG
    Mov Disord; 2012 Feb; 27(2):248-53. PubMed ID: 22162144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing cognition in Parkinson disease: use of the cognitive linguistic quick test.
    Parashos SA; Johnson ML; Erickson-Davis C; Wielinski CL
    J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):228-34. PubMed ID: 19666882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia and mild cognitive impairment in patients with Parkinson's disease.
    Teive HA; Piovesan MR; Werneck LC
    Arq Neuropsiquiatr; 2009 Dec; 67(4):1165; author reply 1165. PubMed ID: 20073125
    [No Abstract]   [Full Text] [Related]  

  • 18. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
    Rasovska H; Rektorova I
    J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Spanish version of the Addenbrooke's Cognitive Examination - Revised (ACE-R) in subcortical ischemic vascular dementia.
    Raimondi C; Gleichgerrcht E; Richly P; Torralva T; Roca M; Camino J; Manes F
    J Neurol Sci; 2012 Nov; 322(1-2):228-31. PubMed ID: 22959102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.